Article
Multi-omics analysis reveals the role of tumor-infiltrating CD4+CCR7+ T cells in EGFR antibody resistance and prognosis of hepatocellular carcinoma
2025-08-21
Abstract excerpt
<title>Abstract</title> <p> <bold>Background</bold> Despite the crucial involvement of the EGFR pathway in hepatocellular carcinoma (HCC), the clinical efficacy of EGFR antibodies in HCC remains uncertain. While existing evidence suggests that immune dysfunction and tumor microenvironment alterations may contribute to treatment resistance, the precise mechanisms underlying this phenomenon in HCC warrant further...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c7062f03-db0e-51a9-8976-60a53161fab2
- DOI
- 10.21203/rs.3.rs-7189781/v1
